Slides
Core Curriculum
• Impact of vascular biology in treatment of cardiovascular disease
Section III: Neurohormonal strategies in heart failure
The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders. The material is presented in four sections:
The material in this section of the slide lecture program discusses new approaches to the treatment of heart failure with a focus on the following areas:
- Insights into the biology of the failing heart and the implications for treatment
- The cardiovascular impact of neurohormonal treatment strategies
- Expanding the use of b-blockade in diverse populations
- ACC/AHA guidelines outlining strategies for early prevention and slowing progression
corerefs.pdf (0.0MB)
Section III: Neurohormonal strategies in heart failure
Download S001.ppt (4 slides - 0.6MB)
Section III: Neurohormonal strategies in heart failure
Download S002.ppt (11 slides - 1.8MB)
Section III: Neurohormonal strategies in heart failure
Download S003.ppt (16 slides - 2.4MB)
Section III: Neurohormonal strategies in heart failure
Download S004.ppt (14 slides - 2.1MB)
Section III: Neurohormonal strategies in heart failure
Download S005.ppt (10 slides - 1.5MB)
Section III: Neurohormonal strategies in heart failure
Download S006.ppt (4 slides - 0.7MB)
Published by Medical Education Consultants, Inc. (MEDCON), on behalf of the University of Florida College of Medicine.
The editorial content of this program does not necessarily reflect the views or recommendations of the University of Florida College of Medicine, AstraZeneca, Aventis Pharmaceuticals, Monarch Pharmaceuticals, Pfizer Inc, or Wyeth Pharmaceuticals.
This program was prepared and produced by Medical Education Consultants, Inc., Westport, Connecticut, on behalf of the University of Florida College of Medicine through an unrestricted educational grant provided by AstraZeneca, Aventis Pharmaceuticals, Monarch Pharmaceuticals, Pfizer Inc, and Wyeth Pharmaceuticals.
©2002 Medical Education Consultants, Inc. (MEDCON). All rights reserved.
basicbiologycardiovascularcoversCurriculumdisordersneurohormonalvascularVBWG